GO
Loading...

Morgan Stanley M&A head on Valeant

Monday, 16 Jun 2014 | 7:45 AM ET

Robert Kindler, vice chairman and head of mergers and acquisitions at Morgan Stanley, gives CNBC an update on Valeant's efforts to buy Botox-maker Allergan